Bia Health Secures $2.15 Million in Pre-Seed Funding
Bia Health, a healthtech company based in Québec City, Canada, has successfully raised $2.15 million in a pre-seed funding round. The company specializes in developing advanced digital tools aimed at enhancing patient outcomes and streamlining clinical workflows for physiotherapists and doctors.
Funding Details and Investors
The funding round was led by Anges Québec, with participation from Desjardins and Finalta Capital. Finalta Capital contributed $1.4 million in debt to the round. This financial backing is expected to help Bia Health broaden the reach of its AI-driven assistant, known as the Bia Assistant, which aids healthcare providers in making more informed diagnostic decisions.
Company Mission and Leadership
Bia Health was co-founded by Anne-Sophie Paquet, who serves as CEO, and Amélie Fournier-Belley, the Chief Product Officer. Paquet, a physiotherapist by profession, explained the company’s mission: “Bia aims to reduce unnecessary and low-value care by helping clinicians make the most appropriate decision for each patient.” The AI assistant is designed to minimize unnecessary medical interventions, such as imaging and referrals, by aligning with evidence-based guidelines.
Strategic Use of Funds
The newly acquired funds are earmarked for scaling the Bia Assistant to reach more clinicians. This involves enhancing the current product to ensure it is more widely adopted within the healthcare sector. The company aims to address a significant issue in the Canadian healthcare system, where approximately 30% of care is deemed unnecessary or low-value.
Looking Ahead
With its AI-driven solutions, Bia Health is well-positioned to make a substantial impact on healthcare delivery by ensuring that medical interventions are both necessary and cost-effective. The company’s focus on practical application of clinical knowledge at the point of care sets it apart as it continues to grow and innovate within the healthtech industry.